Showing results (1531-1540 of 1,839) with videos related to

Sort By:
Pageof 184
Blood|October 1, 1996
Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patientsR L Comenzo, E Vosburgh, R W Simms, et al.
ACS Chemical Neuroscience|June 7, 2017
Why Is Research on Amyloid-β Failing to Give New Drugs for Alzheimer's Disease?Andrew J Doig, Maria P Del Castillo-Frias, Olivia Berthoumieu, et al.
Depression and Anxiety|October 17, 2015
STRESSORS, SYMPTOM PROFILE, AND PREDICTORS OF ADJUSTMENT DISORDER IN CANCER PATIENTS. RESULTS FROM AN EPIDEMIOLOGICAL STUDY WITH THE COMPOSITE INTERNATIONAL DIAGNOSTIC INTERVIEW, ADAPTATION FOR ONCOLOGY (CIDI-O)Bianca Hund, Katrin Reuter, Martin Härter, et al.
Plos One|July 2, 2020
Inequity in access to personalized medicine in France: Evidences from analysis of geo variations in the access to molecular profiling among advanced non-small-cell lung cancer patients: Results from the IFCT Biomarkers France StudySamuel Kembou Nzale, William B Weeks, L'Houcine Ouafik, et al.
Vaccine|February 21, 2026
Safe and durable immune responses to a single dose DNA COVID-19 vaccine in previously vaccinated or SARS-CoV-2-infected adults: A phase 1 studyKhursheed Anwer, Lauren Musso, Ninaad Lasrado, et al.
Health Physics|November 25, 2003
An in situ gamma-ray spectrometry intercomparisonP Shebell, S Faller, M Monetti, et al.
Psycho-Oncology|February 24, 2018
The Generalized Anxiety Disorder Screener (GAD-7) and the anxiety module of the Hospital and Depression Scale (HADS-A) as screening tools for generalized anxiety disorder among cancer patientsPeter Esser, Tim J Hartung, Michael Friedrich, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2019
Molecular basis for AU-rich element recognition and dimerization by the HuR C-terminal RRMNina Ripin, Julien Boudet, Malgorzata M Duszczyk, et al.
Anticancer Research|July 25, 2008
Prostate 25-hydroxyvitamin D-1alpha-hydroxylase is up-regulated by suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitorLilin Wang, Kelly S Persons, Dan Jamieson, et al.
Drug Discovery Today|April 18, 2012
Evidence-based approach to assess passive diffusion and carrier-mediated drug transportLi Di, Per Artursson, Alex Avdeef, et al.
Pageof 184